Application
Fig1: Western blot analysis of Glypican3 on human Glypican3 recombinant protein using anti- Glypican3 antibody at 1/1,000 dilution.
Application
Fig2: Western blot analysis of Glypican3 on different lysates using anti- Glypican3 antibody at 1/1,000 dilution. Positive control: Lane 1: HepG2 Lane 2: HEK293 Lane 3:Jurkat Lane 4: SK-N-SH Lane 5: PC-12 Lane 6: F9 Lane 7: Mouse liver tissue
Application
Fig3: ICC staining Glypican3 (green) and actin filaments (red) in Hela cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Application
Fig4: Immunohistochemical analysis of paraffin-embedded liver cancer tissue using anti- Glypican3 antibody. Counter stained with hematoxylin.
Application
Fig5: Immunohistochemical analysis of paraffin-embedded breast cancer tissue using anti- Glypican3 antibody. Counter stained with hematoxylin.
Application
Fig6: Flow cytometric analysis of Jurkat cells with Glypican3 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).